Real-time enrollment status for this autosomal dominant polycystic kidney disease clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:46 AM UTC
| NCT Number | NCT07228364 |
| Recruiting Status | Recruiting |
| Condition | Autosomal Dominant Polycystic Kidney Disease |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 8 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | May 11, 2026 (May 11, 2026) |
As of July 13, 2026: Clinical trial NCT07228364 is currently recruiting participants. This clinical trial study for autosomal dominant polycystic kidney disease is actively seeking new participants at 8 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07228364 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07228364 was last updated May 11, 2026 (May 11, 2026). HelloStudys verifies this status automatically.